MSOT and MRI – Complementary Modalities for Pre-clinical Imaging
Dr. Mark ‘Marty’ Pagel, Department of Cancer Systems Imaging, MD Anderson Cancer Center
Innovations in Optoacoustic Imaging for Preclinical and Clinical Research
Neal Burton, PhD, Team Lead Applications, iThera Medical
Liver Injury and Tumor Metastasis Imaging with MSOT
Prof Dr Shuizhu Wu, State Key Laboratory of Luminescent Materials & Devices, College of Materials Science & Engineering, South China University of Technology
Multimodal cell tracking by combining gold nanorods and reporter genes
Dr Raphael Levy and
Dr Antonius Plagge, University of Liverpool, UK
Assessing tissue oxygenation in small animal tumor models using MSOT
Dr Sarah Bohndiek, University of Cambridge
Molecular imaging of cancer biomarkers using multispectral optoacoustic tomography (MSOT)
Lacey McNally, PhD, Associate Professor, University of Louisville School of Medicine;
Clinton Hupple, MSc, Application Specialist, iThera Medical
Multispectral Optoacoustic Tomography (MSOT) enters the clinic
Joachim Klode MD, Associate Professor, Dermatologist, University Hospital Essen;
Neal C. Burton PhD, Senior Application Specialist, iThera Medica
MSOT for Imaging Biodistribution and Pharmacokinetics
Wouter Driessen, PhD, Probe Development Scientist, iThera Medical
MSOT – A Versatile New Imaging Modality for Cancer Research
Neal Burton, PhD, Application Specialist, iThera Medical
MSOT for Biomedical Research
Neal Burton, PhD, Application Specialist, iThera Medical